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ABSTRACT 
Materials that participate in bone remodelling at the implant / tissue interface represent a modern 
tissue engineering approach with the aim of balancing implant resorption and nascent tissue 
formation. Silicon-substituted hydroxyapatite (SiHA) ceramics are capable of stimulating new 
bone formation, but little is known about their interaction with osteoclasts (OC). The effects of 
soluble silicate and SiHA on OCs were investigated in this study. Soluble silicate below 500 mM 
did not stimulate cell metabolism at 4 days or alter resorption area at 7 days on calcium 
phosphate discs. On sintered ceramics, OC numbers were similar on HA, Si0.3HA (0.5 wt%Si) 
and Si0.5HA (1.2 wt%Si) after 21 days in vitro, but actin ring sealing zone morphology on SiHA 
resembled that commonly found on bone or on carbonate-substituted hydroxyapatite (CHA). 
Smaller and thicker actin rings on SiHA compared to HA were probably the result of altered 
surface chemistry and solubility differences. The more stable sealing zones and increased lattice 
solubility likely contributed to increased individual pit volumes observed on Si0.5HA. The 
delayed formation of OCs on Si0.5HA (lower numbers at day 14) excludes earlier differentiation 
as a possible mechanism of increased individual OC pit volumes at later times (day 21). 
Materials characterization of Si containing biomaterials remains paramount as the Si type and 
amounts can subsequently impact downstream OC behaviour in a complex manner. 
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INTRODUCTION 
Bone is a dynamic structure that undergoes extensive remodelling via osteoclastic (OC) 
resorption and new tissue formation by osteoblasts (OB). Increased calcium phosphate (CaP) 
resorption by OCs may allow for more bone tissue production when both resorption and bone 
formation are in homeostasis. Studies on bovine cortical bone and synthetic carbonate-
substituted hydroxyapatite (CHA) have suggested that OC resorption may stimulate subsequent 
OB activity or even bone forming ability. 1–3 However, remodelling is known to occur in vivo at 
plasma-sprayed HA surfaces that leads to a gradual loss of the ceramic coating. 4,5 Silicon-
substituted HA (SiHA) has had success in vivo as a synthetic bone-grafting material, but the 
mechanism of increased osteoconduction seen with this material is not well understood. 6 Active 
remodelling of SiHA was suspected as a mechanism for enhanced bone formation in a study by 
Hing et al. where porous SiHA (0.8 wt%) was implanted in a lapine model for 12 weeks. 7 The 
proposed involvement of remodelling in bone formation around implants has led to more 
researchers investigating the effects of biomaterials on OCs. Techniques such as RT-PCR 
(mRNA expression), histological staining (TRAP), fluorescence microscopy of OC sealing zones 
and 3D characterisation of resorption pits have all revealed materials induced OC responses. 8–12  
  Higher dissolution rates from SiHA compared to HA may contribute to the success of 
SiHA as a bone graft material.13 However, the effect of soluble and lattice bound Si on OCs 
remains unclear. Soluble silicate ions [3-100 µM] did not show any stimulatory effects on RAW 
264.7 OCs after 3 days in the presence of SaOS-2 osteosarcoma cells. 14 More recently, 
Mladenović et al. reported that the degradation products of bioglass 45S5 (orthosilicic acid) 
inhibited in vitro phenotypic gene expression, OC formation and resorption of murine cavarial 
bone.15 They found a lower limit of ~690 µM inhibited OC resorption activity. Studies 
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correlating these findings to SiHA are rare, but some groups have investigated OC formation and 
activity on SiHA. 
Botelho et al. first studied the OC response to SiHA using CD14+ peripheral human 
blood monocytes (PBMC).11 Actin and vinculin were visualised around OC sealing zones at 21 
days and increased Ca and P release was seen from SiHA (1.5 wt%), but not HA. Lehmann et al. 
found a wider range of OC lacunae diameters on biphasic α-tricalcium phosphate (TCP) / SiHA 
(1.4 wt% Si) compared to HA at 21 days, but the role of silicon was unclear due to the presence 
of TCP.16 Contrary to these studies, Matesanz et al. found inhibited in vitro OC development and 
reduced resorption on nano grained nSiHA (~0.8 wt% Si) discs calcined at 700 °C compared to 
nano grained nHA at 21 days. 17 However, their functional in vitro OC resorption study was 
limited to resorption pit diameter measurements. More work is needed to clarify OC resorption 
activity on well-characterized SiHA substrates. 
A more detailed study of OC activation may provide more evidence for the effects of 
silicon. Quantitative measurement of actin ring morphology might indicate OC sealing zone 
stability, 18 and area measurement of resorption pits, while useful, may not adequately describe 
OC resorption activity because of differences in pit depth. 9,10 The goals of this study were to 
determine 1) whether soluble silicate, in the presence of RANKL, increased OC resorption of 
CaP coated culture wells, 2) if OC formation on SiHA was enhanced or reduced compared to HA 
and 3) if SiHA altered OC resorption compared to HA. The number of OCs, the morphology of 
sealing zones and resorption pits was also determined.  
MATERIALS AND METHODS 
Materials preparation 
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HA powder (Ca/P ratio 1.667) was prepared using the calcium hydroxide / orthophosphoric acid 
based aqueous wet precipitation method of Jarcho. 19 SiHA (0.8 and 1.5 wt% (x=0.3 and 0.5 in 
Equation 1) with calculated Ca/P ratios of 1.750 and 1.812 respectively) was prepared using 
similar methods, but tetraethylorthosilicate (TEOS, 86578, Sigma Aldrich, UK) was added to the 
calcium hydroxide solution prior to the addition of diluted H3PO4. 20,21 The molar calcium 
amount was decreased by 1% below the calculated Ca/P ratios for SiHA in order to retain phase 
purity and subvert the formation of CaO. HA and SiHA powders were ground in an alumina 
crucible and mechanically sieved below 75 µm before uniaxial pressing in a 13 mm die at 75 
MPa. Discs were then sintered at 1200 °C for 2 hours and ground to a 15 µm (P1200) finish with 
SiC paper before sterilisation by steam autoclave. Sintered disc diameters were ~9.6 mm in 
diameter and ~2 mm thick with theoretical densities >98%. 
Ca10 PO4( )6−x SiO4( )x OH( )2−x  (1) 
Materials characterisation 
The phase structure of HA and SiHA powders heated to 1200 °C was examined using X-ray 
diffraction (XRD). A Philips PW1050 diffractomer (PANalytical, NL) with monochromatic Cu 
Kα radiation was used to scan over a range of 25-50° 2θ and Philips HighScore plus software 
was used to match peaks to appropriate International Centre for Diffraction Date (ICDD) files 
such as HA 09-0432, CaO 37-1497, α-TCP 29-0359 and β-TCP 70-2065. Fourier transform 
infrared spectroscopy (FTIR) was performed on heat-treated powders (1200 °C) using a Bruker 
Tensor 27 in transmission mode (KBr pellets) over the range of 400-4000 cm-1. X-ray 
fluorescence (XRF) analysis of HA and SiHA was outsourced to LSM Analytical (UKAS 1091, 
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UK). 15 different elemental oxides were measured including Ca, Si and P with minimum 
detection limits of 0.05 wt%.  
CD14+ monocyte isolation and OC culture 
The isolation of CD 14+ peripheral blood monocytes (PBMC) was based on the methods 
reported by Schilling, Spence and Botelho et al. 11,12,22 Whole blood was obtained from a healthy 
donor who gave written consent to the Orthopaedic Research Unit, University of Cambridge 
under Local Research Ethics Committee agreement 06/Q0108/213. The procedure of Botelho et 
al. was followed, and CD14+ PBMCs were isolated and suspended in α-Minimum essential 
medium (MEM) (41061 Gibco, Invitrogen, UK) supplemented with heat inactivated 10% AB 
human male serum (CS400 HD Supplies, TCS Biosciences, UK), 1% v/v penicillin, 
streptomycin, glutamine (10 units.ml-1 penicillin, 10 µg.ml-1 streptomycin, 29.2 mg.ml-1 
glutamine, 10378, Gibco) and ascorbic acid (30 µg ml-1).  
The CD14+ PBMCs were counted using a Cell Scepter (Milllipore), diluted to the desired 
concentration and seeded in a bead of 67 µl of media per disc at 3,865 cells.mm-2 on ceramic 
discs or into the wells of Ostelogic CaP-coated slides at 5 x 104 cells.well-2. The samples were 
incubated in a humidified atmosphere containing 5% CO2 at 37 °C for 2 hours. Afterwards the 
wells were flooded with αMEM supplemented with 50 ng mL-1 RANKL (recombinant human 
soluble RANK ligand, 10-1141, Insight Biotech., UK) and 25 ng mL-1 of recombinant human 
macrophage colony stimulating factor (M-CSF, 216-MC, R&D systems, UK). Each ceramic disc 
had 1.0 ml of medium that was changed once every 7 days.  
Sodium silicate preparation 
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A batch of sodium silicate solution (Sigma-Aldrich 338443) with a Si concentration of 13.1% 
(gravimetric assay) and a titrated NaOH level of 13.7% was diluted to give in culture medium to 
give silicon concentrations of 0.005 – 500 mm silicon. 13.7% NaOH solution (Sigma) was 
diluted in deionised water to in the same way to give equivalent NaOH concentrations as control 
solutions. Commercially available CaP coated discs (BD Biocoat Osteologic, BD Biosciences, 
UK) were used as substrates to test whether soluble silicate altered OC resorption behaviour. 
Silicate or NaOH solutions were added to the Osteologic slides 5 days after monocyte seeding 
when multinucleate cells were visible. 
MTS assay  
An MTS assay was used according to the manufacturer’s protocol to determine the viability of 
cells on Osteologic discs 3 days after the addition of silicate (CellTiter 96®AQueous cell 
proliferation assay, Promega). 
Quantifying calcium phosphate resorption 
The effect of soluble silicon on the resorption of calcium phosphate was determined 3 days after 
the addition of silicate. Medium was removed from the Osteologic wells and the cells removed 
by treating with 1% v/v NaOH for 1 hour. Cells were rinsed thoroughly with de-ionised water 
and the remaining calcium phosphate stained using the von Kossa method. 5% w/v silver nitrate 
solution was added for 30 minutes and after rinsing the colour was developed with 5% w/v 
sodium thiosulphate. Discs were rinsed, dried and resorbed areas determined by capturing an 
image of each well area using a Leitz Dialux 20 microscope (Leica) and a Retiga Exi camera 
(QImaging). Areas were measured using PCImage software (Synoptics). 
TRAP staining 
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TRAP has been associated with OCs and active bone resorption, but other cells (such as 
osteocytes or some mononuclear cells) are also known to stain positive for TRAP. 23 Therefore, 
TRAP staining was performed at 21 days with the addition of fluorescent imaging of actin rings 
and multinucleated cells to differentiate OCs from other cell types. The TRAP staining procedure 
as described in Farquharson et al. was used to stain CD14+ PBMCs grown on permanox sides 
for 21 days. 24 
Fluorescent microscopy-actin and nuclei staining 
Fluorescence microscopy was performed on samples at days 14 and 21 on SiHA and HA. The 
cells were washed twice with PBS and fixed in 4% paraformaldehyde solution for 10 minutes. 
Cells were stained using immunocytochemistry techniques similar to those used by Botelho et al. 
where phalloidin TRITC (Sigma Aldrich, UK) diluted 1:1000 in 1% BSA-PBS solution was used 
to stain for F-actin and Vectashield mountant containing 4’,9-diamidino-2-
phenylindoledihydrochloride (DAPI) anti-fade mounting agent (Vector Labs, UK) stained the 
nuclei. 11 A Leica DMRXA 2 fluorescence microscope was used in conjunction with Surveyor 
(Objective imaging version 5.5.5.30) software with an Oasis automation control system in order 
to create a fluorescent mosaic image of the entire sample taken at 10 X magnification. OC 
counting was performed using Image J (NIH, USA) with the cell-counter plug in. An OC was 
defined as having 3 or more nuclei (fluoresced blue) and an actin ring (fluoresced red). Actin 
ring diameters and thicknesses were measured (50 each per sample) near the centre of the discs 
where OCs were confluent. 
2-dimenional imaging of OC resorption pits 
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Resorbed surfaces at days 11 and 21 were gently cleaned and placed in an ultrasonic bath to 
remove cellular material. Dried discs were sputter coated with gold (Emitech 550) and imaged 
using a JEOL 820 scanning electron microscope (SEM) at an accelerating voltage of 10 kV. 
Stereoscopic light microscopy was also performed and the gold coatings increased contrast 
between resorbed / native surfaces. Image J was used to convert the images to black and white 
then a threshold was set by hand to reflect the resorbed area. 
3-dimensional microscopy of OC resorption pits 
A 3D laser colour microscope (VK-9500, Keyence, Japan) was used to measure resorption pit 
volumes within a region of interest (ROI). Win-ROOF 3D software (Mitani Corp., Japan) was 
used to process a mosaic of images (~300 per sample). First, any sample sloping from uneven 
polishing was corrected using a software algorithm. A baseline volume was measured on the as 
polished discs for comparison to the resorbed samples to show that the volume of resorption was 
not a measurement artefact. A 5 mm diameter ROI was selected in an area containing resorption 
pits, and the threshold was set using the laser light images manually with good repeatability. 3 
ROIs were measured per sample, and n=5 samples per condition were measured at day 21. Root 
mean squared roughness (Rq) was also calculated using the WinROOF software. The number of 
pits per ROI was counted at day 21 and individual pit volumes (n=15 per material) were 
measured at day 21. 
Statistics 
Tests for equality of variance and normality were performed before using Analysis of variance 
(ANOVA) with Tukey’s HSD post-hoc testing as necessary. Unless stated otherwise, ANOVA 
and Tukey’s HSD post-hoc testing were used; otherwise a Kruskal-Wallis test was used with a 
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Wilcoxon-Mann-Whitney post-hoc test. Calculations were performed with JMP (SAS) software. 
Error bars in plots represent standard deviation except where indicated otherwise. 
RESULTS 
Materials characterisation 
XRD traces revealed that HA, Si0.3HA and Si0.5HA samples were phase pure after heating to 
1200 °C as shown in [Fig. 1]. The only phase present was ICDD No. 09-0432 for stoichiometric 
HA with a hexagonal crystal system. FTIR revealed major phosphate and hydroxyl peaks 
commonly reported for HA [Fig. 2]. 25 Silicate peaks or shoulders were observed in SiHA [Fig. 
2]. 26,27 No glassy silica Si-O-Si peaks were detected near 800 cm-1, but orthosilicate peaks were 
observed suggesting that these groups were incorporated into the HA structure. XRF determined 
that the amount of silicon in Si0.3HA and Si0.5HA was 0.54 wt% and 1.17 wt% respectively 
[Table 1]. Measured Ca/P ratios were within ± 0.01 and Ca/P+Si ratios were within ± 0.02 of the 
calculated molar ratios [Table 1]. 
Soluble silicate and OC resorption of CaP coated discs 
There was no significant effect of soluble silicate on cell viability as determined by the MTS 
assay [Fig. 3(A)] except at the highest concentration where 500 µm silicate showed a 
significantly lower absorbance than 0.05 µm silicate unlike the 500 mm NaOH control. Similarly 
there was no significant effect of silicate on osteoclast resorption of calcium phosphate when 
compared to the NaOH control with the exception of the highest concentration, 500 µm, where 
osteoclastic resorption was completely prevented [Fig. 3(B)]. 
OC formation on HA and SiHA 
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OC phenotypes were expressed on both HA and SiHA samples that were seeded with PBMCs 
and cultured for 14-21 days. CD14+ PBMCs seeded on permanox slides were TRAP positive 
[Fig. 4(A)] after 21 days, showing these cells were capable of displaying a marker frequently 
associated with OCs. Multinucleated cells with actin rings formed on all materials after 14 and 
21 days [Fig. 4(B)]. OCs tended to form in plaques similarly observed by Spence et al. on HA 
and CHA discs in vitro compared to a more uniform distribution on dentine.12 The presence of an 
actin ring and multiple nuclei is demonstrative of an OC phenotype, 28 so OC numbers were 
counted using this criteria. At day 14, HA and Si0.3HA had significantly higher (p<0.01 and 
p<0.05 respectively) numbers of OCs compared to Si0.5HA [Fig. 5(A)]. Day 21 values were 
significantly (p<0.05) higher than day 14 values. Si0.5HA OC numbers increased rapidly between 
days 14 and 21 to produce the largest mean value at day 21. However, there were no significant 
(p<0.05) differences detected between OC numbers at day 21. 
 The morphology of the actin rings was different between HA and SiHA samples at day 
21. SiHA discs favoured the formation of thicker and smaller OC sealing zones despite the 
similar OC numbers observed at day 21 shown in Fig. 5(A). HA had significantly larger (p<0.01) 
diameter actin rings (130 µm vs. 60 µm) compared to Si0.3HA and Si0.5HA [Fig. 5(B)]. The mean 
actin ring thickness was larger (8 µm vs. 5 µm) on SiHA compared to HA discs [Fig. 5(C)].  
In vitro OC resorption of HA and SiHA substrates 
Resorption area and volume measurements were performed on discs from two independent 
experiments. The resorption area was measured as a percentage of the total disc area from n=4 
samples of each material. There were no significant (p<0.05) differences between resorption area 
on HA, Si0.3HA or Si0.5HA at 11 or 21 days [Fig. 6]. The only significant (p<0.05) difference in 
resorbed area was between Si0.5HA at days 11 and 21. This finding corresponds to the lower 
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concentration of OCs observed on Si0.5HA at 14 days as measured in a separate experiment 
[Fig.5(A)]. 
Volume measurements were made on n=5 samples with 3 ROIs (5 mm diameter) 
measured on each sample. The baseline means at day 0 for volume and Rq were similar and 
significantly lower (p<0.01) than the resorbed discs at day 21 as expected [Fig. 7(A-B)]. The 
mean volume of resorption at 21 days was slightly higher for Si0.5HA compared to HA and 
Si0.3HA, but there were no significant differences (p>0.05) between samples at day 21 [Fig. 
7(A)]. Rq values also increased from day 0 to day 21 samples supporting the resorbed volume 
measurements [Fig. 7(B)]. The largest mean increase in volume between days 0 and 21 was 
Si0.5HA with a change of 0.21 µm (volume.area-1) compared to 0.16 µm and 0.15 µm for HA and 
Si0.3HA respectively. The number of OC resorption pits on Si0.5HA was lower (p<0.05) than on 
HA [Fig. 7(C)], but the mean individual pit volume was almost 4 fold higher on Si0.5HA than on 
HA [Fig. 7(D)]. 
OC resorption areas corresponded to the plaque-like formation of OCs near the centre of 
the discs observed during fluorescence microscopy [Fig. 8(A)]. The resorption pits typically had 
a non-uniform depth [Fig. 8(B)], which necessitated the use of whole surface and individual pit 
volume measurements as opposed to simple measurement of pit depth. The pits highlighted in 
[Figs. 8(B-C Si0.3HA,Si0.5HA)] are likely the products of adjacent or migratory 18,29 OCs that were 
shown to have ~60 µm sealing zones [Fig. 5(B)]. The resorption pit surfaces revealed an inter-
granular structure typical of synthetic CaPs that have been resorbed by OCs or subjected to local 
acidic attack [Fig. 8(C)]. 8,9 
DISCUSSION 
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The aim of this study was to determine whether silicate substitution in HA subsequently altered 
OC formation and resorption behaviour. Silicon substitution induces chemical and structural 
changes in HA that lead to changes in the in vitro OC response as previously suggested in studies 
by Botelho et al. and Lehmann et al. 11,16 OC numbers, actin ring morphology and OC resorption 
pits are important measures of OC development and activity that have not yet been investigated 
on phase pure SiHA. Phase purity was important for this experiment because secondary phases 
could alter the silicate and calcium solubility. It then becomes difficult to draw conclusions about 
whether an OC response was due to SiHA or a secondary phase, such as CaO or TCP. 
SiHA was characterised in this study to confirm phase purity, stoichiometry and the 
presence of silicate ions in HA. The adjusted Ca/P ratio mentioned in the ‘Materials production’ 
section was necessary to obtain phase pure SiHA samples at 1200 °C [Fig. 1]. This was due to 
slightly lower Si amounts [Table 1] in SiHA as measured with XRF compared to the expected 
stoichiometric Ca/P+Si ratios. The decreased Si amounts here are likely the result of incomplete 
hydrolysis of TEOS and inadvertent atmospheric carbonate substitution at room temperature. 30 
Glassy silica (Si-O-Si), undetectable in XRD at low levels, can form in SiHA with larger Si 
amounts (x=0.75 or more) or when using non-aqueous methods of synthesis. 26 Such entities 
could unknowingly impact the outcome of biological studies but were not observed here [Fig. 2].  
OC formation on synthetic HA and SiHA 
The chemistry (including substituting ions such as Zn),31 surface energy,32 solubility 8 and 
topography 33 of materials are all known to impact OC formation and adhesion, which can 
regulate sealing zone architecture and dynamics. 34 All disc surfaces were polished and grain size 
differences were not of a magnitude known to alter OC behaviour so topography was controlled 
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for. 35 Our findings regarding OC formation on SiHA [Fig. 4] agree with Botelho et al. who 
showed that OCs can form on synthetic Si0.3HA, Si0.5HA and HA substrates from CD14+ 
PBMCs with co-localisation of vinculin and actin, indicative of sealing zone formation. 11      
The delayed formation of OCs from PBMCs on Si0.5HA at day 14 [Fig.5 (A)] was 
probably due to differences in surface charge 32 and / or solubility. 36 Matesanz et al. also 
reported inhibited OC formation after 21 days on nSiHA (0.8 wt%) compared to nHA.17 
However, they also reported that the viability of RAW 264.7 murine macrophages was not 
reduced in SiHA compared to HA. The use of murine macrophages, lower concentrations of 
RANKL and a more soluble nano grained nSiHA, could explain the temporal differences 
between their study and this one (reduced OC formation on Si0.5HA at 14 days instead of 21 
days) [Fig.5 (A)]. 
Soluble Si did not show any adverse metabolic effects under 500 µM Si on PBMCs at 3 
days on osteologic CaP substrates [Fig. 3(A)] or on [3-100 µM] RAW 254.7 OCs on tissue 
culture plastic at 3 days. 14 However, at 500 µM Si OC metabolic activity and resorption activity 
on CaP substrates declined [Fig.3]. Similar concentrations of soluble Si (from dissolved bioglass 
45S5 particles) of ~690 µM inhibited OC formation (RAW254.7) and resorption of murine 
calvarial bone in vitro. 15 Ca was likely the dominant factor in any solubility-mediated influence 
Si0.3HA and particularly Si0.5HA had at later time points (day 21) in this study. 37 Hayakawa et al. 
found a non-linear increase in Ca release from SiHA with increasing Si amounts under acidic 
conditions (pH 4.0). 38 Early burst style release of higher Si amounts from Si0.5HA, a passive 
effect (altered surface charge due Si substitution) higher amounts of extracellular Ca or a slightly 
higher pH (above 7.30 pH) could explain the reduced OC numbers and resorption activity at day 
14 for Si0.5HA, and medium changes coupled with decreasing non-steady state Si release might 
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have reduced the effects of Si at day 21 [Figs. 5(A) and 6].37,39,40 However, Ca and Si release 
from SiHA was not quantified in this study because this would not account for re-precipitation of 
soluble Ca, P and or Si on the disc surface. 
 Apatitic matrix can promote sealing zone formation via cellular signalling, 41 but the actin 
ring morphology can vary with subtle changes to stoichiometry or substituting ions. OCs tend to 
form smaller diameter, thicker and more stable actin rings on bone slices and CHA in vitro 
compared to other substrates such as stoichiometric HA, calcite and tissue culture plastic. 9,18 The 
actin ring thicknesses and diameters on SiHA and HA [Fig. 5(B-C)] was comparable to those 
observed on crystalline CHA (8.9 wt% CO3) and HA respectively seen in a separate study. 9 The 
smaller and thicker actin rings on Si0.3HA and Si0.5HA compared to HA [Figs. 5(B-C)] denote 
actin morphology indicative of increased sealing zone integrity that could encourage OC 
resorption. Changes to extracellular ligands that affect actin ring structure could be due to both 
material solubility and material surface chemistry. SiHA is known to have a higher binding 
affinity for collagen,42 and a collagenous matrix is important for OC actin ring formation.43 
Botelho et al. theorized that this phenomenon could lead to enhanced OC resorption activity.11 
OC resorption activity on HA and SiHA 
While smaller and more stable sealing zone morphologies can promote resorption, the rate and 
morphology of OC resorption also depends on material properties such as chemistry, solubility 
and surface area in addition to extracellular pH.18,39,40 Dense crystalline discs were used in this 
study in an attempt to 1) reduce the effects of surface area and 2) allow for consistent confocal 
pit measurement. Yamada et al. highlighted the importance of volume measurements of OC pits 
in their study that showed significant differences in pit depth and pit volume between TCP and 
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ZnTCP, but no difference in the pit area. 10 New confocal imaging techniques have enabled the 
measurement of pit depth, which is frequently non-uniform [Fig. 7(B)], and resorption volume. 
Our findings support a mechanism where Si0.5HA was more susceptible to dissolution in a 
localized low pH (3-4) environment due to increased triple point junctions 36 as opposed to 
earlier OC differentiation from CD14+ PBMCs as observed by Nakamura et al. (15-18 days). 9 
Small changes in extracellular pH (as low as 0.10 units between 7.15 and 7.25 pH) can promote 
or inhibit OC resorption.39,40 The local environment around OCs on SiHA is complex due to 
possible modulation of extracellular pH resulting from the basic dissolution products of SiHA. 
Extracellular pH cannot be excluded as a possible mechanism of enhanced OC resorption here. 
Once OCs developed on Si0.5HA, there were fewer pits on its surface with larger 
individual pit volumes than on HA [Fig. 7(C,D)], but whole disc area and ROI (20 mm2) volume 
measurements didn’t show any significant differences despite slightly elevated means for 
Si0.5HA at 21 days [Figs. 6 & 7(A)]. The reduced pit numbers with larger pit volumes seen with 
Si0.5HA was not due to shallower pits with a larger surface area as both Si0.3HA and Si0.5HA 
showed smaller, well defined pit borders [Fig. 8 (A)] that support the smaller actin ring 
diameters discussed earlier [Fig. 6 (B)]. Therefore the reduced pit numbers per area on Si0.5HA, 
despite larger individual pit volume, likely contributed to a false negative error in ROI volume at 
21 days [Fig. 7(A, C)]. The larger volume pits with fewer pit numbers on Si0.5HA might indicate 
a preferred in vitro OC resorption mechanism (i.e., tunnelling vs. trough (migratory) resorption). 
Resting or migrating OCs can be inhibited with increased extracellular Ca concentrations, 37 so 
the deeper individual pit volumes on Si0.5HA [Fig. 7(D)] indicate a preference for active 
resorption as opposed to migration. 41 The SiHA resorption surfaces also exhibited a more 
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‘etched’ surface clearly exposing grains compared to a HA where grains were not exposed as 
clearly [Fig. 8]. This further supports a solubility mediated OC resorption on SiHA. 
 Complementary reports of OC resorption of SiHA support our findings. The increased Ca 
and P release from Si0.5HA cultured with OCs in vitro for 21 days shown by Botelho et al. also 
suggests an increased susceptibility of Si0.5HA to acidic OC attack. 11 However, Si release was 
not measured here and the possibility of CaP re-precipitation at the HA or SiHA interface was 
not considered. Re-precipitation in Botelho’s study would have only decreased soluble Ca and P 
differences between SiHA with OCs and the control (SiHA only). Lehmann et al. observed 
increased numbers of resorption lacunae on Si0.5HA compared to HA, but their SiHA also 
contained the more soluble α-TCP phase.16 Matesanz et al. observed smaller diameter lacunae on 
nSi0.3HA compared to nHA suggesting a possible reduction in OC activity, but they did not 
report pit numbers or depth information.17  
Although minor increases in CaP lattice solubility may encourage more aggressive OC 
resorption, high amounts of dissolution can have an inverse effect. The work of Detsch et al. 
found that HA was more aggressively resorbed by OCs compared to a more soluble β-TCP. 8 
Studies investigating OB-OC cross talk could reveal whether signalling and/or OC resorption is 
altered in the presence of SiHA. However, one suspected mechanism of enhanced bone 
formation in porous SiHA in vivo was increased remodelling at the tissue/implant surface 
compared to HA 7 requiring a positive effect of SiHA on osteoclast resorption and osteoblast 
activity.  
CONCLUSIONS  
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New in vitro osteoclastogenesis and resorption metrics were used to study the effects of soluble 
Si and SiHA on OCs. Soluble Si under 500 µM did not alter OC metabolic activity or resorption 
on CaP coated discs. Higher initial Si release rates might explain early OC inhibition on Si0.5HA, 
but structurally induced changes in HA due to Si substitution could explain late resorption 
activity on Si0.3HA and Si0.5HA. The smaller and thicker actin ring morphologies on SiHA were 
likely due to both surface energy and solubility differences compared to HA. The larger 
individual pit volumes and delayed OC formation on Si0.5HA suggested increased lattice 
solubility as opposed to earlier OC differentiation as a mechanism for enhanced OC resorption. 
Although recent studies have suggested reduced OC activity as a result of Si, the form (soluble 
monomer, amorphous silica or lattice bound) and amount must be carefully evaluated, as these 
trends were not observed in this study for Si0.3HA or Si0.5HA. 15,17  
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TABLE 1. Calculated and XRF measured Ca/P, Ca.P+Si ratios and Si amounts. 
Sample Ca/P Ca/P+Si wt% Si 
  expected measured expected measured expected measured 
HA 1.67 1.66         
Si0.3HA 1.75 1.75 1.67 1.69 0.85 0.54 
Si0.5HA 1.81 1.82 1.67 1.68 1.50 1.17 
 
 
FIGURE 1. XRD reflections of HA, Si0.3HA and Si0.5HA heated to 1200 °C. * Indicates ICDD # 
09-0432 peaks. Major impurity peaks occur over the 25-50° 2θ. 
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FIGURE 2. FTIR scans of heat treated HA and SiHA (1200 °C). The region from 1200-450 cm-
1 was enhanced to highlight major phosphate, hydroxyl and silicate peaks typical for HA and 
SiHA. SiHA had an oxyhydroxyapatite peak near 950 cm-1. The enhanced region from 3700-
3400 cm-1 highlights the characteristic hydroxyl-stretching peak. 
 24 
 
FIGURE 3. (A) Cellular metabolism as represented by reduction of MTS dye after 4 days in the 
presence of silicate or NaOH (control) and (B) area resorption as a result of 0.005-500 µM 
silicon in the culture medium after 7 days. Values are mean ± s.d.; n=3 for A and mean ± S.E.M.; 
n=3 for B. 
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FIGURE 4. TRAP positive multinucleated cells generated from CD14+ PBMCs after 21 days 
(A). Fluorescence image of nuclei (blue/green) and actin rings (red/yellow) typical of an OC 
after 21 days in vitro on SiHA0.5 (B). The closed arrowheads point towards an actin ring and the 
open headed arrowheads point towards cell nuclei. 
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FIGURE 5. (A) OC numbers counted from fluorescence mosaic images (n=6 samples per 
condition) after 14 and 21 days on HA, Si0.3HA and Si0.5HA. An OC was considered to have at 
least 3 nuclei and an actin ring. (B) Actin ring diameters were measured at day 21 from n=6 
samples per condition (50 ring diameters per sample). (C) Actin ring thicknesses were measured 
at day 21 from n=6 samples per condition (50 thicknesses per sample). Error bars for all plots 
represent s.d. * denotes p<0.05 and ** p<0.01. 
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FIGURE 6. Area resorption as measured by thresholding in Image J (n=4). The only significant 
difference found (* p<0.05) was between areas measured at days 11 and 21 for Si0.5HA. These 
measurements were obtained from an independent experiment from those obtained in Figures 5 
and 7.  
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FIGURE 7. (A) Mean volume resorption per ROI (20 mm2) from n=5 samples per condition (3 
ROIs per disc) before and after in vitro OC culture for 21 days. No differences were detected 
between materials, but differences between measurements at day 0 and 21 were significant 
(p<0.01). (B) Roughness values Rq obtained from traces along the ROIs measured in 3D laser 
microscopy and calculated using the WinROOF software. Again no differences between 
materials were observed, but Rq significantly (p<0.01) increased between day 0 and day 21. (C) 
Number of resorption pits per ROI from n=5 samples per condition (3 ROIs per disc) at 21 days. 
(D) Individual OC pit volumes (n=15 per material) after 21 days. A Kruskal-Wallis and a Mann-
Whitney U post-hoc test were used. 
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FIGURE 8. (A) Macroscale images of OC resorption on the sample surfaces after 21 days. (B) 
Laser image of a resorption pit on Si0.5HA after 21 days. This confocal image shows the non-
uniform morphology typical of OC pits. (C) SEM images of HA, Si0.3HA and Si0.5HA surfaces 
after 21 days with arrowheads indicating an OC resorption pit. 
